nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—CYP3A4—Thiotepa—urinary bladder cancer	0.269	0.687	CbGbCtD
Bedaquiline—CYP3A4—Etoposide—urinary bladder cancer	0.0731	0.186	CbGbCtD
Bedaquiline—CYP3A4—Doxorubicin—urinary bladder cancer	0.0498	0.127	CbGbCtD
Bedaquiline—Blood amylase increased—Thiotepa—urinary bladder cancer	0.0369	0.0618	CcSEcCtD
Bedaquiline—Septic shock—Fluorouracil—urinary bladder cancer	0.022	0.037	CcSEcCtD
Bedaquiline—Septic shock—Etoposide—urinary bladder cancer	0.0191	0.0321	CcSEcCtD
Bedaquiline—Hepatic cirrhosis—Methotrexate—urinary bladder cancer	0.0181	0.0303	CcSEcCtD
Bedaquiline—Amylase increased—Thiotepa—urinary bladder cancer	0.0169	0.0283	CcSEcCtD
Bedaquiline—Amylase increased—Cisplatin—urinary bladder cancer	0.0133	0.0222	CcSEcCtD
Bedaquiline—Transaminases increased—Thiotepa—urinary bladder cancer	0.0132	0.0222	CcSEcCtD
Bedaquiline—Transaminases increased—Gemcitabine—urinary bladder cancer	0.0111	0.0187	CcSEcCtD
Bedaquiline—Septic shock—Epirubicin—urinary bladder cancer	0.0107	0.018	CcSEcCtD
Bedaquiline—Septic shock—Doxorubicin—urinary bladder cancer	0.00993	0.0167	CcSEcCtD
Bedaquiline—Chest pain—Valrubicin—urinary bladder cancer	0.00865	0.0145	CcSEcCtD
Bedaquiline—Myalgia—Valrubicin—urinary bladder cancer	0.00865	0.0145	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.00755	0.0127	CcSEcCtD
Bedaquiline—Hepatic enzyme increased—Gemcitabine—urinary bladder cancer	0.00716	0.012	CcSEcCtD
Bedaquiline—Diarrhoea—Valrubicin—urinary bladder cancer	0.00567	0.00951	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Gemcitabine—urinary bladder cancer	0.00562	0.00943	CcSEcCtD
Bedaquiline—Toremifene—ESR1—urinary bladder cancer	0.00549	0.488	CrCbGaD
Bedaquiline—Dizziness—Valrubicin—urinary bladder cancer	0.00548	0.00919	CcSEcCtD
Bedaquiline—Anorexia—Mitomycin—urinary bladder cancer	0.00544	0.00913	CcSEcCtD
Bedaquiline—Transaminases increased—Epirubicin—urinary bladder cancer	0.00533	0.00893	CcSEcCtD
Bedaquiline—Vomiting—Valrubicin—urinary bladder cancer	0.00527	0.00884	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Thiotepa—urinary bladder cancer	0.00526	0.00882	CcSEcCtD
Bedaquiline—Rash—Valrubicin—urinary bladder cancer	0.00523	0.00876	CcSEcCtD
Bedaquiline—Dermatitis—Valrubicin—urinary bladder cancer	0.00522	0.00876	CcSEcCtD
Bedaquiline—Headache—Valrubicin—urinary bladder cancer	0.00519	0.00871	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.00515	0.00864	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.00501	0.00841	CcSEcCtD
Bedaquiline—Decreased appetite—Mitomycin—urinary bladder cancer	0.00496	0.00832	CcSEcCtD
Bedaquiline—Transaminases increased—Doxorubicin—urinary bladder cancer	0.00493	0.00827	CcSEcCtD
Bedaquiline—Nausea—Valrubicin—urinary bladder cancer	0.00492	0.00826	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.00467	0.00784	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00443	0.00742	CcSEcCtD
Bedaquiline—Haemoptysis—Epirubicin—urinary bladder cancer	0.00438	0.00734	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00433	0.00727	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00426	0.00714	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.00412	0.00692	CcSEcCtD
Bedaquiline—Haemoptysis—Doxorubicin—urinary bladder cancer	0.00405	0.00679	CcSEcCtD
Bedaquiline—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.00397	0.00666	CcSEcCtD
Bedaquiline—Diarrhoea—Mitomycin—urinary bladder cancer	0.00391	0.00655	CcSEcCtD
Bedaquiline—Dizziness—Mitomycin—urinary bladder cancer	0.00378	0.00633	CcSEcCtD
Bedaquiline—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00375	0.00629	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.0037	0.00621	CcSEcCtD
Bedaquiline—Hepatic enzyme increased—Methotrexate—urinary bladder cancer	0.00366	0.00614	CcSEcCtD
Bedaquiline—Vomiting—Mitomycin—urinary bladder cancer	0.00363	0.00609	CcSEcCtD
Bedaquiline—Arrhythmia—Thiotepa—urinary bladder cancer	0.00361	0.00605	CcSEcCtD
Bedaquiline—Rash—Mitomycin—urinary bladder cancer	0.0036	0.00604	CcSEcCtD
Bedaquiline—Dermatitis—Mitomycin—urinary bladder cancer	0.0036	0.00603	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00358	0.00601	CcSEcCtD
Bedaquiline—Headache—Mitomycin—urinary bladder cancer	0.00358	0.006	CcSEcCtD
Bedaquiline—Tamoxifen—ESR2—urinary bladder cancer	0.00356	0.317	CrCbGaD
Bedaquiline—Nausea—Mitomycin—urinary bladder cancer	0.00339	0.00569	CcSEcCtD
Bedaquiline—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.00334	0.0056	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00334	0.0056	CcSEcCtD
Bedaquiline—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00316	0.00529	CcSEcCtD
Bedaquiline—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.00311	0.00522	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00306	0.00513	CcSEcCtD
Bedaquiline—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00304	0.00509	CcSEcCtD
Bedaquiline—Arthralgia—Thiotepa—urinary bladder cancer	0.003	0.00502	CcSEcCtD
Bedaquiline—Myalgia—Thiotepa—urinary bladder cancer	0.003	0.00502	CcSEcCtD
Bedaquiline—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00299	0.00501	CcSEcCtD
Bedaquiline—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00294	0.00493	CcSEcCtD
Bedaquiline—Arrhythmia—Cisplatin—urinary bladder cancer	0.00283	0.00475	CcSEcCtD
Bedaquiline—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00282	0.00472	CcSEcCtD
Bedaquiline—Anorexia—Thiotepa—urinary bladder cancer	0.00274	0.00459	CcSEcCtD
Bedaquiline—Cardiac disorder—Etoposide—urinary bladder cancer	0.00269	0.00452	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00269	0.00451	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00262	0.00439	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.00257	0.0043	CcSEcCtD
Bedaquiline—Arthralgia—Gemcitabine—urinary bladder cancer	0.00252	0.00423	CcSEcCtD
Bedaquiline—Myalgia—Gemcitabine—urinary bladder cancer	0.00252	0.00423	CcSEcCtD
Bedaquiline—Chest pain—Gemcitabine—urinary bladder cancer	0.00252	0.00423	CcSEcCtD
Bedaquiline—Decreased appetite—Thiotepa—urinary bladder cancer	0.0025	0.00419	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00249	0.00418	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00248	0.00416	CcSEcCtD
Bedaquiline—Chest pain—Fluorouracil—urinary bladder cancer	0.00248	0.00415	CcSEcCtD
Bedaquiline—Myalgia—Fluorouracil—urinary bladder cancer	0.00248	0.00415	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.0024	0.00403	CcSEcCtD
Bedaquiline—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00237	0.00397	CcSEcCtD
Bedaquiline—Myalgia—Cisplatin—urinary bladder cancer	0.00235	0.00394	CcSEcCtD
Bedaquiline—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00233	0.00391	CcSEcCtD
Bedaquiline—Anorexia—Gemcitabine—urinary bladder cancer	0.0023	0.00386	CcSEcCtD
Bedaquiline—Anorexia—Fluorouracil—urinary bladder cancer	0.00226	0.0038	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00222	0.00372	CcSEcCtD
Bedaquiline—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00221	0.0037	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.0022	0.00369	CcSEcCtD
Bedaquiline—Tamoxifen—ESR1—urinary bladder cancer	0.00219	0.195	CrCbGaD
Bedaquiline—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00216	0.00363	CcSEcCtD
Bedaquiline—Chest pain—Etoposide—urinary bladder cancer	0.00215	0.00361	CcSEcCtD
Bedaquiline—Anorexia—Cisplatin—urinary bladder cancer	0.00215	0.0036	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.00212	0.00355	CcSEcCtD
Bedaquiline—Decreased appetite—Gemcitabine—urinary bladder cancer	0.0021	0.00352	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00209	0.0035	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00207	0.00348	CcSEcCtD
Bedaquiline—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00206	0.00346	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00205	0.00344	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00205	0.00344	CcSEcCtD
Bedaquiline—Anorexia—Etoposide—urinary bladder cancer	0.00197	0.0033	CcSEcCtD
Bedaquiline—Diarrhoea—Thiotepa—urinary bladder cancer	0.00196	0.00329	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00196	0.00329	CcSEcCtD
Bedaquiline—Decreased appetite—Cisplatin—urinary bladder cancer	0.00196	0.00328	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00194	0.00326	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00192	0.00322	CcSEcCtD
Bedaquiline—Dizziness—Thiotepa—urinary bladder cancer	0.0019	0.00318	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00183	0.00307	CcSEcCtD
Bedaquiline—Vomiting—Thiotepa—urinary bladder cancer	0.00183	0.00306	CcSEcCtD
Bedaquiline—Rash—Thiotepa—urinary bladder cancer	0.00181	0.00304	CcSEcCtD
Bedaquiline—Dermatitis—Thiotepa—urinary bladder cancer	0.00181	0.00303	CcSEcCtD
Bedaquiline—Headache—Thiotepa—urinary bladder cancer	0.0018	0.00302	CcSEcCtD
Bedaquiline—Decreased appetite—Etoposide—urinary bladder cancer	0.00179	0.00301	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00178	0.00299	CcSEcCtD
Bedaquiline—Hepatitis—Methotrexate—urinary bladder cancer	0.00174	0.00292	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00171	0.00288	CcSEcCtD
Bedaquiline—Nausea—Thiotepa—urinary bladder cancer	0.00171	0.00286	CcSEcCtD
Bedaquiline—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00165	0.00277	CcSEcCtD
Bedaquiline—Hepatitis—Epirubicin—urinary bladder cancer	0.00163	0.00273	CcSEcCtD
Bedaquiline—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00162	0.00273	CcSEcCtD
Bedaquiline—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00161	0.00271	CcSEcCtD
Bedaquiline—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.0016	0.00268	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00159	0.00266	CcSEcCtD
Bedaquiline—Dizziness—Fluorouracil—urinary bladder cancer	0.00157	0.00263	CcSEcCtD
Bedaquiline—Diarrhoea—Cisplatin—urinary bladder cancer	0.00154	0.00258	CcSEcCtD
Bedaquiline—Vomiting—Gemcitabine—urinary bladder cancer	0.00154	0.00258	CcSEcCtD
Bedaquiline—Rash—Gemcitabine—urinary bladder cancer	0.00152	0.00255	CcSEcCtD
Bedaquiline—Dermatitis—Gemcitabine—urinary bladder cancer	0.00152	0.00255	CcSEcCtD
Bedaquiline—Headache—Gemcitabine—urinary bladder cancer	0.00151	0.00254	CcSEcCtD
Bedaquiline—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00151	0.00253	CcSEcCtD
Bedaquiline—Vomiting—Fluorouracil—urinary bladder cancer	0.00151	0.00253	CcSEcCtD
Bedaquiline—Hepatitis—Doxorubicin—urinary bladder cancer	0.00151	0.00253	CcSEcCtD
Bedaquiline—Rash—Fluorouracil—urinary bladder cancer	0.0015	0.00251	CcSEcCtD
Bedaquiline—Dermatitis—Fluorouracil—urinary bladder cancer	0.0015	0.00251	CcSEcCtD
Bedaquiline—Headache—Fluorouracil—urinary bladder cancer	0.00149	0.0025	CcSEcCtD
Bedaquiline—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00148	0.00248	CcSEcCtD
Bedaquiline—Arrhythmia—Epirubicin—urinary bladder cancer	0.00145	0.00244	CcSEcCtD
Bedaquiline—Nausea—Gemcitabine—urinary bladder cancer	0.00143	0.00241	CcSEcCtD
Bedaquiline—Vomiting—Cisplatin—urinary bladder cancer	0.00143	0.0024	CcSEcCtD
Bedaquiline—Rash—Cisplatin—urinary bladder cancer	0.00142	0.00238	CcSEcCtD
Bedaquiline—Dermatitis—Cisplatin—urinary bladder cancer	0.00142	0.00238	CcSEcCtD
Bedaquiline—Diarrhoea—Etoposide—urinary bladder cancer	0.00141	0.00237	CcSEcCtD
Bedaquiline—Nausea—Fluorouracil—urinary bladder cancer	0.00141	0.00237	CcSEcCtD
Bedaquiline—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.0014	0.00234	CcSEcCtD
Bedaquiline—Dizziness—Etoposide—urinary bladder cancer	0.00136	0.00229	CcSEcCtD
Bedaquiline—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00135	0.00226	CcSEcCtD
Bedaquiline—Nausea—Cisplatin—urinary bladder cancer	0.00134	0.00224	CcSEcCtD
Bedaquiline—Vomiting—Etoposide—urinary bladder cancer	0.00131	0.0022	CcSEcCtD
Bedaquiline—Rash—Etoposide—urinary bladder cancer	0.0013	0.00218	CcSEcCtD
Bedaquiline—Dermatitis—Etoposide—urinary bladder cancer	0.0013	0.00218	CcSEcCtD
Bedaquiline—Headache—Etoposide—urinary bladder cancer	0.00129	0.00217	CcSEcCtD
Bedaquiline—Arthralgia—Methotrexate—urinary bladder cancer	0.00129	0.00216	CcSEcCtD
Bedaquiline—Chest pain—Methotrexate—urinary bladder cancer	0.00129	0.00216	CcSEcCtD
Bedaquiline—Myalgia—Methotrexate—urinary bladder cancer	0.00129	0.00216	CcSEcCtD
Bedaquiline—Nausea—Etoposide—urinary bladder cancer	0.00123	0.00205	CcSEcCtD
Bedaquiline—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00121	0.00203	CcSEcCtD
Bedaquiline—Myalgia—Epirubicin—urinary bladder cancer	0.00121	0.00202	CcSEcCtD
Bedaquiline—Arthralgia—Epirubicin—urinary bladder cancer	0.00121	0.00202	CcSEcCtD
Bedaquiline—Chest pain—Epirubicin—urinary bladder cancer	0.00121	0.00202	CcSEcCtD
Bedaquiline—Anorexia—Methotrexate—urinary bladder cancer	0.00118	0.00197	CcSEcCtD
Bedaquiline—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00113	0.0019	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00113	0.00189	CcSEcCtD
Bedaquiline—Chest pain—Doxorubicin—urinary bladder cancer	0.00112	0.00187	CcSEcCtD
Bedaquiline—Myalgia—Doxorubicin—urinary bladder cancer	0.00112	0.00187	CcSEcCtD
Bedaquiline—Arthralgia—Doxorubicin—urinary bladder cancer	0.00112	0.00187	CcSEcCtD
Bedaquiline—Anorexia—Epirubicin—urinary bladder cancer	0.0011	0.00185	CcSEcCtD
Bedaquiline—Decreased appetite—Methotrexate—urinary bladder cancer	0.00107	0.0018	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00107	0.00179	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00105	0.00177	CcSEcCtD
Bedaquiline—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00105	0.00176	CcSEcCtD
Bedaquiline—Anorexia—Doxorubicin—urinary bladder cancer	0.00102	0.00171	CcSEcCtD
Bedaquiline—Decreased appetite—Epirubicin—urinary bladder cancer	0.00101	0.00169	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000998	0.00167	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000975	0.00163	CcSEcCtD
Bedaquiline—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00093	0.00156	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000924	0.00155	CcSEcCtD
Bedaquiline—Diarrhoea—Methotrexate—urinary bladder cancer	0.000845	0.00142	CcSEcCtD
Bedaquiline—Dizziness—Methotrexate—urinary bladder cancer	0.000817	0.00137	CcSEcCtD
Bedaquiline—Diarrhoea—Epirubicin—urinary bladder cancer	0.000791	0.00133	CcSEcCtD
Bedaquiline—Vomiting—Methotrexate—urinary bladder cancer	0.000785	0.00132	CcSEcCtD
Bedaquiline—Rash—Methotrexate—urinary bladder cancer	0.000779	0.00131	CcSEcCtD
Bedaquiline—Dermatitis—Methotrexate—urinary bladder cancer	0.000778	0.00131	CcSEcCtD
Bedaquiline—Headache—Methotrexate—urinary bladder cancer	0.000774	0.0013	CcSEcCtD
Bedaquiline—Dizziness—Epirubicin—urinary bladder cancer	0.000765	0.00128	CcSEcCtD
Bedaquiline—Vomiting—Epirubicin—urinary bladder cancer	0.000735	0.00123	CcSEcCtD
Bedaquiline—Nausea—Methotrexate—urinary bladder cancer	0.000734	0.00123	CcSEcCtD
Bedaquiline—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000732	0.00123	CcSEcCtD
Bedaquiline—Rash—Epirubicin—urinary bladder cancer	0.000729	0.00122	CcSEcCtD
Bedaquiline—Dermatitis—Epirubicin—urinary bladder cancer	0.000728	0.00122	CcSEcCtD
Bedaquiline—Headache—Epirubicin—urinary bladder cancer	0.000724	0.00121	CcSEcCtD
Bedaquiline—Dizziness—Doxorubicin—urinary bladder cancer	0.000707	0.00119	CcSEcCtD
Bedaquiline—Nausea—Epirubicin—urinary bladder cancer	0.000687	0.00115	CcSEcCtD
Bedaquiline—Vomiting—Doxorubicin—urinary bladder cancer	0.00068	0.00114	CcSEcCtD
Bedaquiline—Rash—Doxorubicin—urinary bladder cancer	0.000674	0.00113	CcSEcCtD
Bedaquiline—Dermatitis—Doxorubicin—urinary bladder cancer	0.000674	0.00113	CcSEcCtD
Bedaquiline—Headache—Doxorubicin—urinary bladder cancer	0.00067	0.00112	CcSEcCtD
Bedaquiline—Nausea—Doxorubicin—urinary bladder cancer	0.000635	0.00107	CcSEcCtD
